PERSPECTA

News from every angle

← Back to headlines

Humacyte Regains Ex-U.S. Rights to Symvess from Fresenius Medical Care

Humacyte has announced that it has regained the ex-U.S. rights to its product Symvess from Fresenius Medical Care.

24 Apr, 17:47 — 24 Apr, 17:47
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed115d ago

Humacyte regains ex-U.S. rights to Symvess from Fresenius Medical Care

Read full article →

Related Stories

Long-Awaited Trial Begins in Tupac Shakur's 1996 Murder Case

16m ago

Three Killed in Private Helicopter Crash on Greek Island of Sifnos

29m ago

Pirates Seize Commercial Cargo Ship Off Somalia Coast

40m ago

Tupac Shakur's Accused Killer Faces Trial, Jury Hears of Gang Revenge Motive

44m ago

Humacyte Regains Ex-U.S. Rights to Symvess from Fresenius Medical Care | Perspecta News